World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
31819
World Ranking
12153
National Ranking
164

Lauren E. Abrey publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lauren E. Abrey sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 310 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lauren E. Abrey D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lauren E. Abrey sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Lauren E. Abrey is affiliated with the University of Zurich in Switzerland and has contributed primarily to the field of Medicine, with a focus on several subfields including Genetics, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Cancer Research, and Molecular Biology.

Their research covers main topics such as:

  • Glioma Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Brain Metastases and Treatment
  • Cancer Genomics and Diagnostics
  • MRI in cancer diagnosis
  • Vascular Malformations Diagnosis and Treatment
  • Statistical Methods in Clinical Trials

Lauren E. Abrey has published in several venues, including:

  • Journal of Clinical Oncology
  • Neuro-Oncology
  • The Lancet Oncology
  • Annals of Clinical and Translational Neurology
  • Neuro-Oncology Advances

The following are recent papers authored by Lauren E. Abrey, including the year of publication and venue:

  • Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma, 2023, Journal of Clinical Oncology
  • Leveraging external data in the design and analysis of clinical trials in neuro-oncology, 2021, The Lancet Oncology
  • Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma, 2020, Annals of Clinical and Translational Neurology
  • Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02, 2020, Neuro-Oncology Advances
  • Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiation, 2022, Journal of Neuro-Oncology

Their frequent co-authors include:

  • Timothy F. Cloughesy
  • Patrick Y. Wen
  • Catalina Raymond
  • Josep Garcia
  • Benjamin M. Ellingson

Best Publications

  • Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

    Henry S. Friedman;Michael D. Prados;Patrick Y. Wen;Tom Mikkelsen

  • Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

    Olivier L. Chinot;Wolfgang Wick;Warren Mason;Roger Henriksson

  • Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

    Lauren E. Abrey;Tracy T. Batchelor;Andrés J.M. Ferreri;Mary Gospodarowicz

  • Treatment for Primary CNS Lymphoma: The Next Step

    Lauren E. Abrey;Joachim Yahalom;Lisa M. DeAngelis

  • Long-term survival in primary CNS lymphoma.

    Lauren E. Abrey;Lisa M. DeAngelis;Joachim Yahalom

  • Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Prognostic Model

    Lauren E. Abrey;Leah Ben-Porat;Katherine S. Panageas;Joachim Yahalom

  • Strategies to advance translational research into brain barriers

    Edward Neuwelt;N Joan Abbott;Lauren Abrey;William A Banks

  • Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

    Patrick G. Morris;Denise D. Correa;Joachim Yahalom;Jeffrey J. Raizer

  • Combined Immunochemotherapy With Reduced Whole-Brain Radiotherapy for Newly Diagnosed Primary CNS Lymphoma

    Gaurav D. Shah;Joachim Yahalom;Denise D. Correa;Rose K. Lai

  • Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08

    Patrick Y. Wen;W. K Alfred Yung;Kathleen R. Lamborn;Patricia L. Dahia

  • Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.

    Kathleen R. Lamborn;W. K.Alfred Yung;Susan M. Chang;Patrick Y. Wen

  • Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.

    Philip H. Gutin;Philip H. Gutin;Fabio M. Iwamoto;Kathryn Beal;Nimish A. Mohile

  • Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma

    F. M. Iwamoto;L. E. Abrey;K. Beal;P. H. Gutin

  • Long-Term Follow-Up of High-Dose Methotrexate-Based Therapy With and Without Whole Brain Irradiation for Newly Diagnosed Primary CNS Lymphoma

    Igor T. Gavrilovic;Adília Hormigo;Joachim Yahalom;Lisa M. DeAngelis

  • A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

    Jeffrey J. Raizer;Lauren E. Abrey;Andrew B. Lassman;Susan M. Chang

  • Phase I Study of Intraventricular Administration of Rituximab in Patients With Recurrent CNS and Intraocular Lymphoma

    James L. Rubenstein;Jane Fridlyand;Lauren Abrey;Arthur Shen

  • R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

    Antonio Omuro;Denise D. Correa;Lisa M. DeAngelis;Craig H. Moskowitz

  • Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial

    Thomas Sandmann;Richard Bourgon;Josep Garcia;Congfen Li

  • Delayed Neurotoxicity in Primary Central Nervous System Lymphoma

    Antonio M. P. Omuro;Leah S. Ben-Porat;Katherine S. Panageas;Amy K. Kim

  • Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide

    Roelien H. Enting;Alexis Demopoulos;Lisa M. DeAngelis;Lauren E. Abrey

Frequent Co-Authors

Lisa M. DeAngelis
Lisa M. DeAngelis Memorial Sloan Kettering Cancer Center
Michael D. Prados
Michael D. Prados University of California, San Francisco
Timothy F. Cloughesy
Timothy F. Cloughesy University of California, Los Angeles
Patrick Y. Wen
Patrick Y. Wen Harvard University
Katherine S. Panageas
Katherine S. Panageas Memorial Sloan Kettering Cancer Center
David Schiff
David Schiff University of Virginia
Susan M. Chang
Susan M. Chang University of California, San Francisco
Kathleen R. Lamborn
Kathleen R. Lamborn University of California, San Francisco
Tracy T. Batchelor
Tracy T. Batchelor Brigham and Women's Hospital
W. K. Alfred Yung
W. K. Alfred Yung The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a medical career in the USA, there are several online degree options that can help expand your opportunities—whether you wish to move into advanced nursing, leadership, or specialized roles. For those interested in mental health, the shortest online pmhnp programs offer a fast track to becoming a Psychiatric Mental Health Nurse Practitioner. These online programs allow you to complete your advanced training while balancing work and other commitments.

Aspiring healthcare leaders may want to explore a master’s in administration. There are plenty of cheapest mha programs online that provide an affordable pathway to healthcare management. If you’re seeking even more options, a master’s in healthcare administration online is highly regarded and can lead to roles in hospital administration, consulting, or public health policy.

For those looking to reach the highest level of clinical practice, consider one of the cheapest dnp programs online. Earning your DNP can prepare you for advanced leadership, research, and teaching roles in the evolving healthcare landscape.

Best Scientists Citing Lauren E. Abrey

Trending Scientists

Recently Published Articles